858-677-6760
Sales@Broadpharm.com
Login
Cart
Home
Products
Categories
Applications
PEG Linkers
ADC Linkers
Antibody, Antibody Drug Conjugates
NEW
Click Chemistry Reagents
Polymer PEG, Copolymer
PROTAC
Lipids In Drug Delivery
Nucleoside, Nucleotide, Phosphoramidite
Fluorescent Dye
Biotinylation reagents
Dye Antibody Labeling Kit
Biotin Antibody Labeling Kit
Protein Crosslinking Kit
Enzyme, Antibody, Substrate
PEG Linkers
Alkyne PEG
Benzyl-PEG
Branched PEG
DNP-PEG
Fmoc PEG
m-PEG
PEG Acid
PEG PFP ester
PEG Tosylate
PROTAC Linker
Thiol PEG
Amino PEG
Biotin PEG
Bromo PEG
DOTA reagent
Hybrid Linkers
Maleimide Linkers
PEG Aldehyde
PEG Phosphonate
PEG-X-PEG
SPDP PEG
Aminooxy PEG
Bis-PEG-acid
DBCO PEG
Enzymatically Cleavable Linkers
Hydroxy PEG
MeNH-PEG
PEG Azide
PEG PNP carbonate
Photocleavable Linkers
Sugar PEG
APN PEG
Bis-PEG-NHS
Diketone Linkers
Fluorescent reagent
Iodo PEG
Non-PEG linker
PEG Hydrazide
PEG Silane
Poly PEG
TCO-PEG
BCN-PEG
Boc-PEG
Disulfide Linkers
Fluorine PEG
Lipid PEG
NOTA reagent
PEG NHS ester
PEG Sulfonic acid
Propargyl PEG
Tetrazine-PEG
PEGylation of Protein, Peptide & Oligo
Antibody Drug Conjugates
Drug Delivery, Surface Modification
PROTAC
Proteomics
Amine Reactive
Bis-PEG-acid
Bis-PEG-NHS
Boc-PEG
Fmoc PEG
PEG Acid
PEG Aldehyde
PEG NHS ester
PEG PFP ester
PEG Phosphonate
PEG Silane
PEG Tosylate
Poly PEG
Carbonyl Reactive
Aminooxy PEG
Carboxyl and Active ester Reactive
Amino PEG
Click Chemistry Reactive
Alkyne PEG
BCN-PEG
DBCO PEG
PEG Azide
TCO-PEG
Tetrazine-PEG
Lipid Molecules
Branched Lipid
Cationic Lipid
Cholesterol
Cholesterol
Helper Lipid
Ionizable Lipid
Other Lipid
PEG Lipid
Phospholipid
Multi-arm PEG
Branched PEG
Thiol Reactive
Bromo PEG
Maleimide Linkers
Order
Support
Custom Service
Protocols
QA/QC
Magic Link Guide
Works Cited
About
Company Info
Blog
Customer Feedback
Careers
Contact
United States
Distributors
Login
Cart
Ifinatamab deruxtecan
Home
/
Products
/
Antibody, Antibody Drug Conjugates
/
Antibody Drug Conjugates (ADC)
/
Ifinatamab deruxtecan
Ifinatamab deruxtecan
Catalog #: bp-50191
Catalog #
Unit
Price
Qty
BP-50191
1 mg
$650.00
BP-50191
5 mg
$1650.00
Usually ships within 24 hours.
Would you like to inquire about custom quantity?
Inquire
Overview
Ifinatamab deruxtecan (I-DXd) is an investigational potential first-in-class B7-H3 directed ADC. B7 homolog 3 (B7-H3), a transmembrane immunoregulatory protein, is overexpressed in several tumor types, including small cell lung cancer (SCLC), where about two-thirds of patients have moderate-to-high expression of B7-H3, which has been associated with disease progression and lower survival. Ifinatamab deruxtecan is comprised of a humanized anti-B7-H3 IgG1 monoclonal antibody attached to a number of topoisomerase I inhibitor payloads (an exatecan derivative, DXd) via tetrapeptide-based cleavable linkers. Ifinatamab deruxtecan was granted orphan drug designation by the U.S. Food and Drug Administration in April 2023 and by the European Commission in February 2024 for the treatment of SCLC. It has average molecular weight of 153KDa. The DAR is n = ~4. This product is for research use only.
Product Details
Species Reactivity
Human
Type
Antibody-drug conjugate
ADC antibody
Ifinatamab (Anti-B7-H3 Monoclonal Antibody)
ADC cytotoxin (drug)
Dxd
Immunogen
B7 homolog 3 (B7-H3)
DAR (Drug to Antibody Ratio)
~4
Purity
98%
Molecular Weight
153kDa
Protein Concentration
10mg/ml
Storage Condition
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Storage Buffer
PBS buffer pH7.4
Images
Datasheets and Documents
Datasheet BP-50191.pdf
Other Related Products
Trastuzumab-MMAE
Trastuzumab-MMAF
Ado-Trastuzumab emtansine (KADCYLA®)
Trastuzumab-DM4